Dishman Carbogen Amcis Limited (DCAL)
ISIN: - Industry: Biotechnology Sector: Healthcare Website
98.8
-0.4(-0.4%)

Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry in India and internationally. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitizers, antiseptics, vitamin D analogues, cholesterol, lanolin-related products, disinfectant formulations, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was founded in 1983 and is headquartered in Ahmedabad, India. As of March 30, 2022, Dishman Carbogen Amcis Limited operates as a subsidiary of Adimans Technologies LLP.

Pricing Updates

TODAY'S HIGH

100.5

TODAY'S LOW

98

52 WEEK HIGH

258.4

52 WEEK LOW

90.1

Major Holders

% of Shares Held by
All Insider

69.32%

% of Shares Held by
Institutions

5.17%

% of Float Held by
Institutions

16.85%

Number of Institutions
Holding Shares

12

Company Overview

MARKET CAP

1549.01 Cr.

ETERPRISE VALUE

3189.63 Cr.

NO. OF SHARES

15.67 Cr.

BOOK VALUE

353.687

DIV. YIELD

0.2%

DEBT

2038.26 Cr.

GROSS PROFIT

1573.28 Cr.

CASH

421.29 Cr.

REVENUE

2285.63 Cr.

REVENUE/SHARE

146.487

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-171.15 Cr.-9.18 Cr.-27.67 Cr.67.84 Cr.
Change To Liabilities235.71 Cr.-81.45 Cr.190.12 Cr.8.65 Cr.
Total cashflows from Investing Activities-618.53 Cr.-380.79 Cr.-441.74 Cr.-169.02 Cr.
Net Borrowings190.16 Cr.44.12 Cr.3.24 Cr.-45 Cr.
Total Cash from Financing Activities130.37 Cr.-11.04 Cr.-97.77 Cr.-102.20 Cr.
Other Liabilities46.77 Cr.85.79 Cr.101.04 Cr.-118.16 Cr.
Total Assets0000
Net Income18.01 Cr.-165.13 Cr.158.51 Cr.210.33 Cr.
Change in Cash-133.30 Cr.121.60 Cr.45.62 Cr.10.80 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities354.85 Cr.513.43 Cr.585.14 Cr.282.03 Cr.
Depreciation307.59 Cr.217.95 Cr.194.09 Cr.151.54 Cr.
Other Cashflows from Investing Activities5.29 Cr.49.84 Cr.-1.27 Cr.-51 Lakhs
Dividends Paid00-3.23 Cr.-3.23 Cr.
Change to Inventory-143.30 Cr.90.91 Cr.-33.37 Cr.-64.06 Cr.
Change to Account Receivables-59.36 Cr.221.87 Cr.-125.56 Cr.-90 Lakhs
Other Cashflows from Financing Activities-59.79 Cr.-52.85 Cr.-61.13 Cr.-57.20 Cr.
Change to Net Income-50.57 Cr.141.95 Cr.99.99 Cr.94.25 Cr.
Capital Expenditures-463.80 Cr.-366.03 Cr.-408.56 Cr.-308.11 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax-4.25 Cr.-65.03 Cr.197.20 Cr.308.79 Cr.
Minority InterestNoneNoneNoneNone
Net Income23.78 Cr.70.91 Cr.321.42 Cr.423.56 Cr.
Selling General Administrative981.49 Cr.882.23 Cr.772 Cr.771.80 Cr.
Gross Profit1674.84 Cr.1350.50 Cr.1494.50 Cr.1567.90 Cr.
Ebit23.78 Cr.70.91 Cr.321.42 Cr.423.56 Cr.
Operating Income23.78 Cr.70.91 Cr.321.42 Cr.423.56 Cr.
Other Operating Expenses361.98 Cr.177.87 Cr.206.67 Cr.220.62 Cr.
Interest Expense-56.81 Cr.-39.03 Cr.-44.86 Cr.-47.62 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense-22.26 Cr.100.10 Cr.38.69 Cr.98.46 Cr.
Total Revenue2140.69 Cr.1912.03 Cr.2043.60 Cr.2058.60 Cr.
Total Operating Expenses2116.91 Cr.1841.12 Cr.1722.18 Cr.1635.04 Cr.
Cost of Revenue465.85 Cr.561.53 Cr.549.10 Cr.490.70 Cr.
Total Other Income Expense Net-28.03 Cr.-135.94 Cr.-124.22 Cr.-114.77 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.18.01 Cr.-165.13 Cr.158.51 Cr.210.33 Cr.
Net Income Applicable to Common Shares18.01 Cr.-165.13 Cr.158.51 Cr.210.33 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets115.09 Cr.156.65 Cr.129.35 Cr.120.97 Cr.
Capital Surplus04738.76 Cr.4741.08 Cr.4777.72 Cr.
Total Liabilities3088.51 Cr.2625.78 Cr.2484.75 Cr.1949.37 Cr.
Stock Holder Equity5548.94 Cr.5698.82 Cr.5715.06 Cr.5379.09 Cr.
Minority Interest0000
Other Liabilities506.69 Cr.252.92 Cr.290.89 Cr.225.15 Cr.
Total Assets8637.45 Cr.8324.60 Cr.8199.81 Cr.7328.46 Cr.
Common Stock31.36 Cr.31.36 Cr.31.38 Cr.32.28 Cr.
Retained Earnings0350.69 Cr.515.07 Cr.399.75 Cr.
Other Liabilities558.56 Cr.507.90 Cr.438.54 Cr.388.66 Cr.
Good Will3645.68 Cr.3581.01 Cr.3684.71 Cr.3470.29 Cr.
Treasury Stock5517.58 Cr.578.01 Cr.427.53 Cr.169.34 Cr.
Other Assets219.25 Cr.426.38 Cr.424.95 Cr.359.65 Cr.
Cash172.09 Cr.243.54 Cr.121.94 Cr.76.32 Cr.
Current Liabilities1419.79 Cr.1248.80 Cr.1568.95 Cr.1198.30 Cr.
Long Term Asset Charges3.25 Cr.10.24 Cr.6.40 Cr.7.95 Cr.
Short Long Term Debt658.83 Cr.119.48 Cr.126.63 Cr.138.99 Cr.
Other Stockholder Equity5517.58 Cr.578.01 Cr.427.53 Cr.169.34 Cr.
Property Plant Equipment2786.88 Cr.2441.46 Cr.2092.96 Cr.1676.36 Cr.
Total Cur. Assets1838.72 Cr.1662.64 Cr.1778.97 Cr.1553.57 Cr.
Long Term Investments31.83 Cr.56.46 Cr.88.87 Cr.147.62 Cr.
Net Tangible Assets1788.17 Cr.1961.16 Cr.1901 Cr.1787.83 Cr.
Short Term Investments292.53 Cr.101.71 Cr.105.01 Cr.11.13 Cr.
Net Receivables516.36 Cr.414.57 Cr.634.39 Cr.497.62 Cr.
Long Term Debt761.96 Cr.503.54 Cr.241.30 Cr.329.07 Cr.
Inventory645.12 Cr.515.65 Cr.580.87 Cr.548.62 Cr.
Accounts Payable193.37 Cr.163.02 Cr.283.52 Cr.194.57 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account